-   Training & Support

[Expand/Collapse all sections]Expand all

This document outlines details of the PBS for patients with moderate to
severe hidradenitis suppurativa (HS).

Moderate to severe hidradenitis suppurativa and listing dates

Moderate to severe hidradenitis suppurativa is a chronic skin condition
featuring lumps in places such as the armpits or groin.

Listing dates: adalimumab - 1 July 2017.

See Written Authority Required Drugs for further information.

Enquiries

Transfer enquiries about prescription arrangements to the Complex Drugs
Programs team and choose the option relevant to the condition treated.

The Resources page contains links to restriction and item codes, contact
details, forms and the PBS and Services Australia websites.

Related links

Written Authority Required Drugs

Process telephone Authority approval application

Online Pharmaceutical Benefits Scheme (PBS) Authorities System (OPA)

Processing Complex Authority Required Listings

Processing and National Demand Allocation (PaNDA)

Online Pharmaceutical Benefits Scheme (PBS) Authorities System (OPA
System)

                                   

-   Services Australia ABN 90 794 605 008 
